EBI3 and Burkitt lymphoma: The differential expression profile of EBI3 observed among BL and DLBCL defined by molecular profiling was next confirmed at the protein level by analyzing by immunohistochemistry with anti-EBI3 mAb, 23 cases of classic BL and 138 cases of DLCBL (Figure 2A).